Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Health care practices must ‘have a playbook’ to prepare for, respond to cyberattacks Josh Friedman
• Adults with Graves’ disease treated with antithyroid drugs at higher risk for some cancers Michael Monostra
• Continuous glucose monitor sensors now approved to be worn during imaging procedures
• Diabetes risk may worsen for women with ‘string of pearls’ PCOS appearance Regina Schaffer
• Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases Michael Monostra
• Eating more meat may increase risk for developing type 2 diabetes Michael Monostra
• FDA panel votes against sotagliflozin for glucose control in type 1 diabetes, CKD Erik Swain
• GLP-1 drugs may reduce uterine fibroid risk for women with type 2 diabetes Regina Schaffer
• GLP-1 therapy may reduce suicidal ideation risk for adolescents with obesity Michael Monostra
• GLP-1s reduce incident hypertension risk for adolescents with obesity Erin T. Welsh, MA
• Many people with ultraprocessed food addiction not identified as needing treatment Scott Buzby
• Medication hesitancy when addressing patients’ obesity-related atherosclerotic risk Scott Buzby
• Obesity drugs could help lower alcohol intake Scott Buzby
• ‘Obesity is the new hypertension’: The current landscape of pharmacological weight loss Scott Buzby
• Obesity prevalence in US has more than doubled over 30 years, projected to rise even more Erik Swain
• Physicians should ‘remain vigilant,’ warn about PCOS misinformation on TikTok Regina Schaffer
• Q&A: Intuitive eating can help people with diabetes improve their relationship with food Bonnie R. Giller, MS, RDN, CDN, CDCES; Susan Weiner, MS, RDN, CDN, CDCES, FADCES
• Q&A: Tips for navigating use of diabetes devices in schools Michael Monostra; Christine A. March, MD, MS
• SELECT ‘legitimized obesity medical therapy’ for treatment of cardiometabolic disease Scott Buzby
• Swallowable capsule that expands in stomach shows weight-loss, cardiometabolic benefit Scott Buzby
• Text, web-based health intervention improves weight trajectories for children up to age 2 Erin T. Welsh, MA
• Timing of mild maternal hypothyroidism ‘pivotal’ for predicting pregnancy outcomes Erin T. Welsh, MA
• Tirzepatide safe, effective for weight loss, preventing diabetes progression at 3 years Scott Buzby
• Tirzepatide shows ‘practice-changing’ CV benefits for obesity-related heart failure Regina Schaffer
• Utilizing machine learning plus clinical features accurately predicted PCOS Erin T. Welsh, MA
• VIDEO: Common endocrine-disrupting chemicals may impact reproductive aging in women Regina Schaffer; Jodi Flaws, PhD
• VIDEO: Hybrid Complete Health Improvement Program feasible for patients with type 2 diabetes Rebecca L. Forand; Thomas B Morland, MD
• VIDEO: Sleep physiology and risk for Alzheimer’s, obesity and CV events Virend K. Somers, MD, PhD
• VIDEO: Update on anticipated Standards of Care document for obesity treatment Jamy Ard, MD, FTOS
• VIDEO: ‘We are in a new era of the treatment of obesity,’ but inequity concerns persist Erin T. Welsh, MA